11 May 2016
LCPN10, a novel oral testosterone undecanoate formulation has been shown to be safe and efficacious for the treatment of hypogonadal patients, according to a study being presented during the 111th Annual Scientific Meeting of the American Urological Association (AUA).
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024